Ahhhhhhhh you could be onto something there nccmtt...my only question is the language used in the PR which specifically states "exclusive".
Not sure how that affects IPCI's already existing deal with PAR as it doesn't seem likely that PAR would give up its exclusivity on the other FocalinXR strengths but only IPCI, PAR and TEVA truly know right!
Good speculation on your part...and worthy of further discussion!